作者: Michele Carron , Fabio Baratto , Francesco Zarantonello , Carlo Ori
DOI: 10.2147/CEOR.S100921
关键词:
摘要: Objective The aim of the study is to evaluate clinical and economic impact introducing a rocuronium–neostigmine–sugammadex strategy into cisatracurium–neostigmine regimen for neuromuscular block (NMB) management.